The effect of azithromycin treatment on respiratory morbidity in children with down syndrome
Abstract Background Children with Down syndrome (DS) often experience recurrent and prolonged hospitalizations from respiratory infections. While Azithromycin has been increasingly used for lower-respiratory tract infections (LRTIs) in children, its potential benefits for DS patients are unexplored....
Saved in:
Main Authors: | Inbal Golan-Tripto, Omer Dor, Noga Arwas, Itai Hazan, Guy Hazan, Aviv Goldbart |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-01-01
|
Series: | BMC Pediatrics |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12887-025-05421-1 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Correction: The effect of azithromycin treatment on respiratory morbidity in children with down syndrome
by: Inbal Golan-Tripto, et al.
Published: (2025-02-01) -
Azithromycin in the Management of Upper Respiratory Tract Infections (URTIs): Indian Real-Life Experience
by: Dominic M, et al.
Published: (2025-01-01) -
Exploring Azithromycin’s Neuroprotective Role in Traumatic Brain Injury: Insights into Cognitive and Motor Recovery and Neuroinflammatory Modulation
by: Mohannad A. Almikhlafi, et al.
Published: (2025-01-01) -
The virome composition of respiratory tract changes in school-aged children with Mycoplasma pneumoniae infection
by: Dianqi Zhang, et al.
Published: (2025-01-01) -
Editorial: Respiratory dysfunction in neurological disease and injury: novel mechanisms and potential therapeutics
by: Savannah Lusk, et al.
Published: (2025-01-01)